TCI GENE Inc. (6879.TWO)

77.80 +0.30 (+0.39%) At close: 10:43AM CST

TCI GENE Inc.

No. 185 Gangchen Road
10th Floor Neihu District
Taipei
Taiwan
886 2 2658 1218
https://www.genext.me

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Description

TCI GENE Inc. provides precision preventive medicines in Taiwan. It offers genetic testing for nutrient metabolism and weight management; G2 and ACE2 genetic testing; supplements; skin care, antiaging, kids' growth, and Alzheimer disease products; and serum for DNA types. The company also provides nutrition consultation services. TCI GENE Inc. is based in Taipei, Taiwan.

Corporate governance

TCI GENE Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.